1. Home
  2. VMI vs BLCO Comparison

VMI vs BLCO Comparison

Compare VMI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VMI
  • BLCO
  • Stock Information
  • Founded
  • VMI 1946
  • BLCO 1853
  • Country
  • VMI United States
  • BLCO Canada
  • Employees
  • VMI N/A
  • BLCO N/A
  • Industry
  • VMI Metal Fabrications
  • BLCO Ophthalmic Goods
  • Sector
  • VMI Industrials
  • BLCO Health Care
  • Exchange
  • VMI Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • VMI 6.9B
  • BLCO 6.3B
  • IPO Year
  • VMI N/A
  • BLCO 2022
  • Fundamental
  • Price
  • VMI $328.56
  • BLCO $17.67
  • Analyst Decision
  • VMI Strong Buy
  • BLCO Buy
  • Analyst Count
  • VMI 2
  • BLCO 12
  • Target Price
  • VMI $383.50
  • BLCO $20.55
  • AVG Volume (30 Days)
  • VMI 119.3K
  • BLCO 558.2K
  • Earning Date
  • VMI 02-18-2025
  • BLCO 02-19-2025
  • Dividend Yield
  • VMI 0.73%
  • BLCO N/A
  • EPS Growth
  • VMI 101.97
  • BLCO N/A
  • EPS
  • VMI 14.66
  • BLCO N/A
  • Revenue
  • VMI $4,053,266,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • VMI N/A
  • BLCO $17.32
  • Revenue Next Year
  • VMI $2.44
  • BLCO $5.98
  • P/E Ratio
  • VMI $22.25
  • BLCO N/A
  • Revenue Growth
  • VMI N/A
  • BLCO 18.01
  • 52 Week Low
  • VMI $202.01
  • BLCO $13.16
  • 52 Week High
  • VMI $354.13
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • VMI 53.60
  • BLCO 50.11
  • Support Level
  • VMI $322.96
  • BLCO $16.99
  • Resistance Level
  • VMI $336.15
  • BLCO $17.72
  • Average True Range (ATR)
  • VMI 6.69
  • BLCO 0.48
  • MACD
  • VMI -0.33
  • BLCO 0.10
  • Stochastic Oscillator
  • VMI 31.94
  • BLCO 69.50

About VMI Valmont Industries Inc.

Valmont Industries Inc is an investment holding company. It operates through two segments namely Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment. The infrastructure segment consists of the manufacture and distribution of products and solutions to serve the infrastructure markets of utility, renewable energy, lighting, transportation, and telecommunications, and coatings services to preserve metal products. Geographically, it derives a majority of its revenue from North America.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: